We're using our first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for cancer and autoimmune disorders.
Location: United States, California, San Diego
Employees: 11-50
Total raised: $73M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | RA Capital... | racap.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.04.2018 | Series C | $63M | - |
| 20.07.2016 | Series B | $10M | RA Capital... |
Mentions in press and media 15
| Date | Title | Description | Source |
| 01.04.2024 | Впервые в мире почку свиньи изменили генетически и пересадил... | Хирурги из США провели человеку трансплантацию почки, полученной из генетически модифицированной сви... | incrussia.... |
| 13.07.2018 | George Golumbeski's first stop out of Celgene: Grail; Roiva... | → Three months after quietly slipping out the back door at Celgene, George Golumbeski has tak... | endpts.com... |
| 30.04.2018 | Synthorx Raises $63M in Series C Financing | Synthorx Inc., a La Jolla, Calif.-based biotechnology company using synthetic biology to discover an... | finsmes.co... |
| 30.04.2018 | Startup developing semi-synthetic protein therapies raises $... | In the near term, Synthorx is leveraging this technology to tame interleukin-2 (IL-2). Arguably the ... | medcitynew... |
| 30.04.2018 | Synthorx Announces $63M Series C Funding | SAN DIEGO, CA, Synthorx Inc. announced today the completion of a $63 million Series C financing, l... | vcnewsdail... |
| 20.07.2016 | RA Capital Leads $10M Series B for Synthorx | Synthorx Inc. announced today the completion of a $10 million Series B financing, led by RA Capital ... | citybizlis... |
| 20.07.2016 | Synthorx Raises $10M | San Diego-based Synthorx, a developer of protein therapeutics technology, said it has raised $10M in... | socaltech.... |
| 20.07.2016 | Synthorx Announces $10M Series B Funding | SAN DIEGO, CA, Synthorx Inc. announced today the completion of a $10 million Series B financing, l... | vcnewsdail... |
| 20.07.2016 | Synthorx Completes $10M Series B Financing | Synthorx Inc., a La Jolla, Calif.-based biotechnology company using synthetic biology to discover an... | finsmes.co... |
| 20.07.2016 | Synthorx receives $10M to pivot toward treatments | The influx of capital will fund a significant evolution at Synthorx, which has been focused on valid... | medcitynew... |
Show more